ATG Individualized Dosing Model in URD-PBSCT.

Clinical trial NCT06572462 · RECRUITING

Trial details

NCT number: NCT06572462
Sponsor: Chinese PLA General Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cytomegalovirus Infections Infection Reactivation Stem Cell Transplant Complications

Start date: 2020-12-31
Primary completion: 2024-12-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.